AllDocs -> cancers

Rachel's Environment & Health News #266 - Brain Cancer Is Rapidly Increasing December 31, 1991 Brain cancer is relatively rare, accounting for only 2% of all cancers, but it seems to be increasing rapidly in children and in people over 65 in the U.S. The latest figures from the National Cancer Institute indicate that brain cancer in the elderly (ages 75-84) is doubling every 9 years [1, pg. 1621; 2, pg. 635.] In 1991 in the U.S., an estimated 16,700 new cases of brain cancer were diagnosed and an estimated 11,500 deaths occurred. [3, pgs. I.15-I.16] The causes of brain cancer are unknown. Brain cancer is usually fatal; the average (median) time between diagnosis and death is about nine months. [1, pg. 1621.] The average survival rate after 5 years is 25%, but in people over 65 the 5-year survival rate is only 4%. [3, pg. I.16.] ...

“Speaking Freely” Proposed Cell Phone – Brain Cancer Public Re-Education Project SPOT 1: Public Service Message first rough concept storyboards april 1999 copyright imaginalia unltd. prepared for: Ed Herriman, PR chair, North American Cellular Communications Device Manufacturing Association (NACCDMA) Page 2 Notes. These boards were created under the assumption that Matthew Perry will be available. His agent did say he’s looking to do more of this kind of spot. If, however, he falls through, Paul Reiser would also work, or, possibly, Ray Romano. Jerry Seinfeld would also be nice but obviously prohibitively expensive for this kind of civic-minded project. Anyway. Properly executed, this approach will go a long way, as discussed, towards allaying widespread and constantly increasing ...

Identification of candidate cancer -causing genes in mouse brain tumors by retroviral tagging PNAS August 3, 2004 • Reporter: Tian Su • 23/01/2005 Page 2 AIM BACKGROUND EXPERIMENTAL PROCESS RESULT SUMMARY Page 3 AIM Develop a system allowing for the retroviral tagging of candidate genes in malignant brain tumors. Page 4 BACKGROUND Page 5 Background(1) Why retroviral tagging ? • R etroviral insertional mutagenesis in mice causes a high incidence of tumors • Proviral tagging is a powerful method to identify cancer -related genes in hematopoietic tumors. • Retroviral tagging has not yet been applicable to solid tumors ,except the mouse mammary tumor virus ...

# Daily News Friday, Jan. 21, 2005 5 NEWS “I’ve earned an 800 GMAT and helped 30 clients markedly improve. Now, I can help you.” - Shawn Berry Earn your personal-best GMAT score. Call:650.776.7373 www.perfectgmat.com Learn one-to-one from the world’s foremost GMAT expert. “I’ve earned an 800 GMAT and helped 7 of my last 10 clients exceed 700. Now, I can help you.” — Shawn Berry Corporate & Residential Wiring Business Telephone Systems & Voicemail Sales, Service & Installation Maintenance & Troubleshooting Voice Over IP Conversion & Installation Internet Data Conferencing Internet based Surveillance 24/7 Phone System Support Vendor Neutral Office Relocation Specialists Free Initial Consultation & Estimates PHONE AND ...

Cancer in Northern Ireland 1993 - 2001: A Comprehensive Report 115 20: Cancer of the Brain (C71) Incidence In 2001, malignant primary cancer of the brain was the fifteenth most common cancer in males and twentieth commonest in females. On average, 60 males and 45 females were diagnosed as having cancer of the brain each year i.e. approximately 1% of all cancers registered. Age The median age at diagnosis was 56 years for males and 57 years for females. Given the levels of disease in 2001, the risk of getting cancer of the brain before the age of 75 years was 1 in 151 for males and 1 in 210 for females (Table 20a). Examination of the age-specific incidence rates show that males twenty years and older had consistently higher levels of this cancer than females (Figure 20a). Prevalence In Northern Ireland on 31st December 2001, there were 121 males and ...

Brain Cancer Vaccine Boosts Immune System to Kill Tumor Cells DURHAM, N.C. -- A cancer vaccine developed by Duke University Comprehensive Cancer Center researchers is showing promise in mice of treating brain tumors that had been thought "off limits" for the immune system. The study, published in the Sept. 17 issue of the Proceedings of the National Academy of Science, shows that the immune system can combat brain tumors, and it appears to do so by a different mechanism than in the rest of the body. The researchers say the finding has important implications for designing future immunological strategies to combat brain cancer . The study was funded by the National Institutes of Health, the American Association of Neurological Surgeons and the American Brain Tumor Association. "The finding shows that we can induce a successful immune response against brain tumors and that we can ...

EFORE the advent of GKS, fractionated radiotherapy and resection were the mainstays of treatment for brain metastases. Now, GKS offers effective tumor control and a relatively long survival period for patients compared with the natural history of the disease. Moreover, it does so while causing minimal morbidity and essentially no deaths. Radiosurgery can be used to treat multiple metas- tases during the same procedure and permits treatment of deep deposits considered surgically inaccessible. 3,4,8–11,16–18, 20,23,24 To date, however, the influence of factors such as WBRT, tumor histology, tumor volume, patient age, preop- erative KPS score, control of the primary disease, and the presence of extracranial metastatic disease on the outcome of lung carcinoma brain metastases after GKS remain the subject of debate. 9,12,15,19,22,25 The aim of this study was ...

Treatments and Therapy for Cancer ( Brain )1 © Alyssa Laures, Buena Vista University 2004. Running head: Treatments and Therapy for Cancer ( Brain ) Treatments and Therapy for Cancer ( Brain ) Alyssa Laures Buena Vista University Page 2 Treatments and Therapy for Cancer ( Brain )2 © Alyssa Laures, Buena Vista University 2004. There are so many different forms of cancer out in the world today that many people die from and there still is not a cure out there, however, there are many possible treatment options available that may help expand a patient’s life expectancy or even put them into remission. I would like to talk about some of the therapies that each patient does go through such as chemotherapy, surgery, radiation, and a few other therapy options. It seems as though that there are not many people out there that have been touched by cancer ...

Primary brain and other central nervous system (CNS) cancers made up 1.4 percent of the incident (newly diagnosed) cancers reported to the Ohio Cancer Incidence Surveillance System (OCISS) for the years 1997 through 2001 (Table 1). Primary tu- mors, or those tumors that originate in the brain or CNS, serve as the focus of this report. The average annual age-adjusted brain and other CNS cancer incidence rate during this time period was 6.8 cases per 100,000 residents (an average of 784 cases per year). Average annual numbers and rates represent the number of cases diagnosed per year on average, not the total number of cases diagnosed during the five-year time period. The average annual age-adjusted U.S. (SEER 1 ) incidence rate for 1997-2001 was 6.4 cases per 100,000 residents, which is about 6 percent less than the rate for Ohio. Completeness of reporting of brain and ...

New Treatment for Brain Cancer Suggested lead: Researchers say they are encouraged by the results of early phase clinical trials of an experimental new treatment for brain cancer . Tom Britt has more. Cut 1SOQ:60 . ( Preview this in a WAV file in 16-bit mono. ) Researchers at the Duke Comprehensive Cancer Center have started testing a new method for killing cancerous brain tumor cells. It's a new class of drugs called "immunotoxins" -- consisting of a bacterial toxin that has been genetically altered and combined with a protein that makes the killer bacteria avoid normal cells and attack only the cancerous cells in the brain . Duke neurosurgeon Dr. John Sampson is the lead investigator in the study, which involves injecting the immunotoxin directly into the brain . "What we're able to do is basically percolate the drug through the brain using this micro-infusion technology." ...

www.calgaryhealthregion.ca November 23, 2004 Issue #123 Our people. Our work. Our values. TACKLING INFLUENZA 2 MEN’S HEALTH DAY 3 s the plane carrying Jo O’Callaghan prepared to land at Baghdad airport in April 2003, the pilot issued a polite warning. “Our pilot told us to brace our- selves for our arrival in Baghdad, but I could never have been prepared for such an emo- tionally challenging experience,” the Calgary Health Region nurse said. “Even though we hear reports, you can never be prepared for the effect years of instabil- ity, violence and devastation has had on the people. They have nothing – less than noth- ing – every time I turned around I was on the brink of tears.” An Emergency Department nurse at the Oilfields Hospital in Black Diamond, O’Callaghan was one of four Red Cross delegates ...

Cannabis may block growth of brain cancer By James Hamilton Cannabis chemicals may provide a new way of treating deadly brain cancer . Scientists have shown that cannabinoids – the chemicals responsible for the drug’s “high” – deter the growth of blood vessels which feed the tumour. They appear to prevent genes making a protein called VEGF (vascular endothelial growth factor) that stimulates the sprouting of blood vessels. Cutting off tumours’ blood supply is one of the latest anti- cancer strategies being explored by scientists. In studies cannabinoids significantly reduced the activity of VEGF in laboratory mice. They also lowered VEGF levels in tumour tissue samples taken from two patients with glioblastoma multiforme, the most lethal brain tumour type. About 4400 new cases of brain tumour are diagnosed in the UK each year. A small percentage of these are grade four gliomas, the ...

Date Received: __ Approved by: Meeting Date: 1/13-14/05 Charge Code: 7471-23 National Cancer Institute Brain SPORE Meeting San Francisco, CA TRAVEL EXPENSE STATEMENT Full Name: Meeting Date: __1/13-14/05__ Address to which check should be mailed (Please print clearly.): Daytime Phone: __ E-mail: _ MEALS AND LODGING Date Meals & Incidental Expenses Lodging (including tax) 1/12 $__ ($38.25 max if TD) $ billed to master 1/13 $__ ($51.00 max if NTD) $ billed to master 1/14 $__ ($38.25 max if TD) $ TOTAL (1) $ (2) $ GROUND TRANSPORTATION EXPENSES (Shuttle, Bus, Parking, Tolls, Taxis) Date Items/Explanation Cost 1/12 $ 1/14 $ TOTAL (3) $ POV (Privately Owned Vehicle) Date ...

Researchers Use Crippled Poliovirus to Attack Brain Cancer DURHAM, N.C. -- In a daring yet successful experiment to cure deadly brain tumors, researchers have combined the cancer -killing properties of poliovirus together with a harmless genetic coding element from the common cold. The resulting modified virus created a remarkably strong anti- cancer agent that rapidly killed cancer cells in laboratory cell cultures and in animals -- and without causing polio, said Matthias Gromeier, M.D., assistant professor of molecular genetics and microbiology at the Duke Comprehensive Cancer Center. Testing of the new viral agent in humans should begin within two years, he said. In the study, the modified poliovirus rapidly killed cancer cells derived from primary brain tumors as well as cells derived from breast and colon cancer metastases -- all within a matter of four to six hours. In ...

H E L P I N G Y O U L E A R N M O R E A B O U T Y O U R H E A L T H Brain Tumors According to the Brain Tumor Society, more than 100,000 Americans will be diagnosed with a brain tumor over the next year. In children and young adults, brain tumors are the second leading cause of cancer death. The cause is unknown, but certain factors can increase its risk, such as exposure to radiation or having an impaired immune system. In rare cases, brain tumors run in families. In adults, roughly 60 percent of all primary brain tumors (originating in the brain ) are malignant astro- cytomas, such as an anaplastic astrocytoma or glioblastoma multiforme. These tumors grow very rapidly and often spread, invading nearby ...

We look forward to seeing you at our seminars ADVECTUS LIFE SCIENCES INC. - PRE-CLINICAL BRAIN CANCER TESTING UNDERWAY July 1, 2002 - Canada Newswire - Investments, Health AVX: TSX VENTURE WKN. 693000 BERLIN AVXSF. NASD VANCOUVER, July 1 /CNW/ - Advectus Life Sciences Inc. announced today that pre-clinical testing of its patented nanoparticle based technology (Nanocure(TM)) has commenced at the University of North Carolina Brain Tumor Center. This series of studies will test the Nanocure(TM) formulation P80DOX- NP on rodent brain metastases arising from lung carcinoma (2), breast carcinoma, melanoma, renal cell carcinoma, and colon carcinoma. P80DOX-NP is a novel method for the delivery of doxorubicin across the blood- brain barrier. The above study design will be a randomized, placebo- controlled study measuring survival as a surrogate ...

brain cancer Brain Cancer and How It Works By: Cheryl Pogue What is Brain Cancer (or a tumor)? Is a malignant tumor of potentially unlimited growth that expands locally by invasion and systemically by metastasis. Also abnormal tissue in the brain . What Causes Cancer Lifestyle Environment Heredity Injury Types of Brain Tumors The first kind is Benign, they have clearly defined edges, contain healthy normal looking cells and do not spread and rarely grow back once removed. Types of Tumors Continued Another type is Malignant, also called brain cancer . They have irregular borders and they are made up of abnormally shaped cells. They spread quickly by sprouting new “roots” into surrounding tissue. Symptoms ...

989 Am J Epidemiol 2003;157:989–997 American Journal of Epidemiology Copyright © 2003 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 157, No. 11 Printed in U.S.A. DOI: 10.1093/aje/kwg082 Parental Occupational Exposure to Pesticides and Childhood Brain Cancer Edwin van Wijngaarden 1 , Patricia A. Stewart 2 , Andrew F. Olshan 1 , David A. Savitz 1 , and Greta R. Bunin 3 1 Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC. 2 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD. 3 Children’s Hospital of Philadelphia, Philadelphia, PA. Received for publication October 2, 2002; accepted for publication December 13, 2002. The authors ...